Las Vegas, NV (PRWEB) January 25, 2006
Nutri Pharmaceuticals Research, Inc. (NRPR.PK), a leading developer and marketer of powdered nutritional ingredients, announced that it has entered into a product development and supply partnership with Aloecorp, Inc., the world’s leading vertically-integrated supplier of bioactive Aloe vera raw materials, for the use of an aloe vera crystal flake produced through the Aloecorp Qmatrix™ Proprietary Processing Technology.
Aloecorp will supply NPRI with a dried aloe vera crystal flake for use as a carrier matrix with NPRI’s O2P™ oil-to-powder conversion process. In addition, both firms will work together on developing powdered oil product concepts using the aloe vera crystal flake.
“Use of the aloe vera crystal flake as a carrier for our O2P Powders adds a unique, bioactive ingredient to our existing powders,” noted NPRI president, Godfrey Yew. Recent clinical studies have shown that use of Aloe vera improves the bioavailability of certain nutrients such as Vitamin C and Vitamin E by over 200%. “Using our patented O2P oil-to-powder technology and the aloe vera crystal flake will enable food marketers and nutraceutical manufacturers to utilize the DHA, GLA, EPA and anti-oxidant properties found in many oils in a more production-friendly and flexible dry powder form.”, Yew continued.
According to Wayne McCune, senior vice president, Aloecorp, Inc., “Developing a range of powders using O2P technology and our Qmatrix aloe vera crystal flake will enable us to help beverage suppliers and food producers develop unique, efficacious functional foods and beverages. Plus if will offer dietary supplement and cosmeceutical manufacturers an exciting opportunity for patented, health-specific products.”
Nutri Pharmaceuticals Research, Inc. (http://www.o2p.us) provides a wide range of powdered oils for functional food, food supplement, cosmetic, pet food and animal feed applications. The company is one of a select few to be awarded the prestigious Nutrition Business Journal “Product Merit Award” for its patented O2P™ Powderization Process
At the heart of its oil powders is the O2P Oil-to-Powder technology. This patented process converts most edible oils, gels or pastes into a free-flowing powder without affecting the isomeric structure, fatty acid profile, color, taste or aroma of the base oil. O2P does not rely on traditional techniques that utilize extremes in heat or cold, or micro-encapsulation technology. This facilitates food marketing and supplement producers’ ability to create functional foods and nutraceuticals by adding anti-oxidants, specific EFAs, or other fatty acids such as EPA, GLA, DHA, and CLA to assist in maintaining specific health issues. The company currently offers more than 50 shelf-stable powders. The company can also apply O2P technology to a third-party’s oil, paste or gel through an arrangement called tolling. Based in Las Vegas, Nevada USA, the company has representative sales offices near Chicago, Amsterdam, San Jose (Costa Rica) and Bangkok. Nutri Pharmaceuticals Research, Inc. shares are currently traded in the United States on the “Pinksheets” under the symbol NRPR.PK.
Aloecorp, Inc. (http://www.aloecorp.com) and sister company Unigen Pharmaceuticals, Inc. (http://www.unigenpharma.com) are subsidiaries of Univera, Inc. Unigen and Aloecorp each focus on identifying and studying the unique ingredients of medicinal botanicals (Aloecorp’s focus is on Aloe vera) and then formulating proprietary raw materials for use in cosmeceutical, nutraceutical and pharmaceutical products.
Aloecorp is a multinational company providing research-proven, bioactive Aloe vera ingredients to world markets. Since its inception in 1988, Aloecorp has been the world’s leading vertically-integrated supplier of raw Aloe vera materials. All of Aloecorp’s raw Aloe vera materials have been scientifically tested for biological activity, certified pure by the International Aloe Science Council, and clinically supported in published, peer-reviewed studies. Aloecorp provides raw Aloe vera materials to finished goods manufacturers in the nutritional and dietary supplement, functional food, cosmeceutical, personal care and pharmaceutical industries.
Forward Looking Statements
The words "believe," "expect," "anticipate" and other similar expressions generally identify forward-looking statements. Forward-looking statements are based on the company's current expectations and are subject to market, competitive and regulatory factors and the other risks and uncertainties indicated from time to time in the company's filings with the Securities and Exchange Commission. Actual results can differ materially. The company makes no commitment to disclose any revisions to forward-looking statements
Mr. Godfrey Yew
Nutri Pharmaceuticals Research, Inc.
Mr. Wayne McCune
Senior Vice President, Sales and Marketing
+360 486 7400
# # #